Fenimore Christopher R. 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Dec 18, 2024
Insider Transaction Report
Form 4
Fenimore Christopher R.
VP, Controller
Transactions
- Tax Payment
Common Stock
2024-12-16$730.81/sh−491$358,828→ 16,265 total
Holdings
- 25(indirect: By Trust)
Common Stock
- 25(indirect: By Trust)
Common Stock
- 1,897(indirect: By Trust)
Common Stock
- 1,515(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.